MainRexult study aims to carefully evaluate a cohort of patients with schizophrenia and related disorder prescribed with the combination therapy with Abilify Maintena and Rexulti on its efficacy and tolerability in a real-life clinical setting.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change from baseline score of the Brief Psychiatric Rating Scale-24 at 3rd and 6th months
Timeframe: 6 months
Change from baseline score of the Clinical Global Impression Scale at 3rd and 6th months
Timeframe: 6 months
Change from baseline score of the Hamilton Anxiety Rating Scale at 3rd and 6th months
Timeframe: 6 months
Change from basline score of the Hamilton Depression Rating Scale at 3rd and 6th months
Timeframe: 6 months